Human Papillomavirus Infection: Recommended vaccinations
Back to search
Export to spreadsheet
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 		 Vaccination not funded by the National Health system
 		 Mandatory vaccination
Years
9101112131415171819202425263045≥ 46
Austria
HPV9 (F/M)
HPV9 (F/M)1
Belgium
HPV9 (F/M)2
HPV9 (F/M)
Bulgaria
HPV9 (F/M)3
HPV9 (F/M)4
Croatia
HPV9 (F/M)
HPV9 (F/M)5
Cyprus
HPV9 (F/M)
HPV9 (F/M)6
Czechia
HPV9 (F/M)
HPV (F/M)7
Denmark
HPV9 (F/M)
HPV9 (F/M)
Estonia
HPV9 (F/M)8
HPV9 (F/M)8
Finland
HPV2 (F/M)9
HPV2 (F/M)10
France
HPV9 (F/M)11
HPV9 (F/M)12
Germany
HPV (F/M)13
HPV (F/M)14
Greece
HPV9 (F/M)15
HPV9 (F/M)16
Hungary
HPV9 (F/M)17
Iceland
HPV9 (F/M)18
HPV9(F)19
Ireland
HPV9 (F/M)
HPV9 (F/M)20
Italy
HPV9 (F/M)21
HPV9 (F/M)22
Latvia
HPV9 (F/M)
HPV9 (F/M)23
Liechtenstein
HPV9 (F/M)24
HPV9 (F/M)25
Lithuania
HPV9 (F/M)26
HPV9(F)27
Luxembourg
HPV9 (F/M)
HPV9 (F/M)
Malta
HPV9 (F/M)28
HPV9(F)29
Netherlands
HPV2 (F/M)
Norway
HPV2 (F/M)30
HPV2 (F/M)
Poland
HPV (F/M)31
HPV2 (F/M)
Portugal
HPV9 (F/M)32
HPV9 (F/M)33
Romania
HPV9 (F/M)
HPV9(F)
Slovakia
HPV9 (F/M)
HPV9 (F/M)
Slovenia
HPV9 (F/M)
HPV9 (F/M)
Spain
HPV (F/M)34
HPV (F/M)34
Sweden
HPV9 (F/M)35
HPV (F/M)36
HPV9 (F/M)37

Footnotes:

  1. Catch-up until 30 years of age free of charge with a 3 doses regimen from 21 years of age.
  2. In the French-speaking community, the target age group is 13-14 years old.
  3. Females 10-14 years, males 10-13 years
  4. Catch-up HPV vaccination target age group: females 15–26 years, males 14–26 years.
  5. The regular catch-up programme is targeted 9-25 years old group for both genders.
  6. Funded up to 17 years and for risk groups up to 26 years.
  7. 3 doses
  8. As of February 2023, boys included in the programme - one dose scheme. free catch-up for 15-18-year-olds
  9. more information available at https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/hpv-eli-papilloomavirusrokote
  10. 2 doses under 15 years old and 3 doses from 15 years and older.
  11. The extension of HPV vaccination to boys aged 11 to 14 with catch-up vaccination for those aged between 15 and 19. This recommendation is applicable since January 1, 2021.
  12. Girls and boy catch-up vaccination recommended with a three-dose schedule at 0, 1-2 and 6 months
  13. 2 or 9-valent. Gender-neutral (boys and girls) vaccination offered since 2018. Two-dose schedule at 0 and 6 months (if the interval between doses is <6 months, a third dose is recommended).
  14. 2 or 9 valent. Catch up in 15-17 years with a three-dose schedule.
  15. Catch-up vaccination up to 18 years for those who missed out on vaccination (HPV vaccine is fully reimbursed in boys and girls aged 15-18 until 31.12.2023). 2 doses scheme up to 15 years with 6 months interval between doses, thereafter 3 doses. for specific at-risk groups vaccination can be extended up to 26 years.
  16. Catch-up vaccination up to 18 years for those who missed out on vaccination (HPV vaccine is fully reimbursed in boys and girls aged 15-18 until 31.12.2025). 2 doses scheme up to 18 years. for specific at-risk groups vaccination can be extended up to 26 years.
  17. School-based vaccination in 7th grade (for girls and boys) with 9-valent vaccine, on a voluntary-based approach, free of charge
  18. As of 1.7.2023, gender neutral HPV vaccination. nine valent.
  19. For more information: https://island.is/en/cervical-cancer-screening/hpv-infection
  20. HPV catch-up vaccination is recommended for unvaccinated females and males under the age of 25 years.
  21. For more information: https://www.salute.gov.it/new/it/tema/vaccinazioni/adolescenti-11-18-anni/
  22. For men at least up to and including 18 years of age, if they have not previously been vaccinated or have not completed the vaccination cycle. For women up to and including 26 years of age. https://www.salute.gov.it/new/it/tema/vaccinazioni/adolescenti-11-18-anni/
  23. Additional population groups who have not been previously vaccinated: women and men aged 18 to 25 (inclusive); women aged 18–55 diagnosed with cervical adenocarcinoma in situ (AIS), and those before or after surgical treatment for high-grade cervical dysplasia (HSIL); women aged 18–45 with precancerous lesions-CIN 2/3 (cervix), VaIN 2/3 (vagina), VIN 2/3 (vulva), AIN 2/3 (anal canal); women and men aged 18–45 with immunosuppression (excluding HIV); women and men aged 18–45 with HIV.
  24. Gender-neutral (boys and girls) 9-valent vaccination offered. Two-dose schedule.
  25. Gender neutral vaccination catch up. 3 doses with 9-valent.
  26. Boys are vaccinated as part of the immunization program with a two-dose schedule (6 months a part). Girls are vaccinated with a three-dose schedule at 0, 1-2 and 6 months. Two doses are free while the third dose is not funded.
  27. Catch-up target age for males is 12-13 years old.
  28. 9-valent. Two dose schedule at 0 and 6 months. Free of charge at 12 years of age. In case of catch up after the age of 14, 3 doses are recommended, with the first 2 doses given 1-2 months apart and the third dose given 5 months after the second dose.
  29. Individuals born as of the year 2000 are eligible for free HPV vaccination.
  30. Gender-neutral (boys and girls) vaccination offered in schools (seventh grade) since 2018. 2-valent
  31. HPV2/9
  32. 9-valent. Two-dose schedule at 0 and 6 months. Applicable to boys born from 2009.
  33. Individuals can start vaccination up to the age of 17 and complete it up to the age of 26.
  34. 2/4/9 valent. More information: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/docs/VPH_recomendaciones_vacunacion_estrategia1dosis.pdf
  35. 9-valent. Gender-neutral (boys and girls) vaccination - School-based programme offered in fifth grade from August 2020.
  36. Catch up campaign. Children 13-17 years are offered catch-up vaccinations free of charge through school health care.
  37. Funding varies by region https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-vaccination-mot-hepatit-b-/?pub=56936